Pharmaceutical utilisation and costs before and after bariatric surgery

International Journal of Obesity

Volumn 37, Issue 11, 2013, Pages 1467-1472

  Keating, C L ^a   Peeters, A ^b   Swinburn, B A ^a   Carter, R ^a   Moodie, M L ^a  

^a DEAKIN UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

bariatric surgery; cost; economic; gastric banding; healthcare; pharmaceutical

Indexed keywords

VITAMIN;

ADULT; ANEMIA; ARTICLE; ASTHMA; BARIATRIC SURGERY; CARDIOVASCULAR DISEASE; COST BENEFIT ANALYSIS; COST CONTROL; DIABETES MELLITUS; DRUG UTILIZATION; FEMALE; GASTRIC BANDING; GASTROINTESTINAL DISEASE; HUMAN; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICARE; MENTAL DISEASE; OBESITY; PAIN; PRESCRIPTION; PRIORITY JOURNAL; RHEUMATIC DISEASE;

ADULT; AUSTRALIA; CARDIOVASCULAR DISEASES; COMORBIDITY; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; DRUG COSTS; FEMALE; GASTROPLASTY; HUMANS; INSURANCE, HEALTH; LAPAROSCOPY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; OBESITY, MORBID; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRESCRIPTION DRUGS; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 84887854353     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2013.24     Document Type: Article

References (65)

1. Walls HL, Wolfe R, Haby MM, Magliano DJ, de Courten M, Reid CM et al. Trends in BMI of urban Australian adults, 1980-2000. Public Health Nutr 2010; 13: 631-638.
2. Freedman DS, Khan LK, Serdula MK, Galuska DA, Dietz WH. Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA 2002; 288: 1758-1761.
3. Neovius M, Teixeira-Pinto A, Rasmussen F. Shift in the composition of obesity in young adult men in Sweden over a third of a century. Int J Obes 2008; 32: 832-836.
4. Hensrud DD, Klein S. Extreme obesity: a new medical crisis in the United States. Mayo Clin Proc 2006; 81: S5-10.
5. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999; 282: 1523-1529.
6. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 122: 481-486.
7. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994; 17: 961-969.
8. Glenny AM, O'Meara S, Melville A, Sheldon TA, Wilson C. The treatment and prevention of obesity: a systematic review of the literature. Int J Obes Relat Metab Disord 1997; 21: 715-737.
9. Norris SL, Zhang X, Avenell A, Gregg E, Brown TJ, Schmid CH et al. Long-term non-pharmacologic weight loss interventions for adults with type 2 diabetes. Cochrane Database Syst Rev 2005; CD004095.
10. Maggard MA, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ, Livingston EH et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005; 142: 547-559.
11. O'Brien PE, Brown WA, Dixon JB. Obesity, weight loss and bariatric surgery. Med J Aust 2005; 183: 310-314.
12. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-2693.
13. Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008; 299: 316-323.
14. Sjostrom L, Peltonen M, Jacobson P, Sjostrom CD, Karason K, Wedel H et al. Bariatric surgery and long-term cardiovascular events. JAMA 2012; 307: 56-65.
15. Sjostrom L, Gummesson A, Sjostrom CD, Narbro K, Peltonen M, Wedel H et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol 2009; 10: 653-662.
16. Karlsson J, Taft C, Ryden A, Sjostrom L, Sullivan M. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. Int J Obes 2007; 31: 1248-1261.
17. Dixon JB, Dixon ME, O'Brien PE. Depression in association with severe obesity: changes with weight loss. Arch Intern Med 2003; 163: 2058-2065.
18. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741-752.
19. Australian Government Department of Health and Ageing. Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee-December 2008. Available from: http://www.health.gov.au/internet/main/pub-lishing.nsf/ Content/pbacguidelines-index. Accessed May 5, 2010.
20. Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses. Panel on cost-effectiveness in health and medicine. JAMA 1996; 276: 1339-1341.
21. United Kingdom National Institute for Clinical Excellence. NICE guidelines: Incorporating health economics in guidelines and assessing resource impact. UAvailable from: http://www.nice.org.uk/niceMedia/pdf/ GuidelinesManualChapter8.pdf. [Accessed May 13, 2010].
22. Snow LL, Weinstein LS, Hannon JK, Lane DR, Ringold FG, Hansen PA et al. The effect of Roux-en-Y gastric bypass on prescription drug costs. Obes Surg 2004; 14: 1031-1035.
23. Segato G, Busetto L, De Luca M, De Stefano F, Marangon M, Salvalaio S et al. Weight loss and changes in use of antidiabetic medication in obese type 2 diabetics after laparoscopic gastric banding. Surg Obes Relat Dis 2010; 6: 132-137.
24. Potteiger CE, Paragi PR, Inverso NA, Still C, Reed MJ, Strodel 3rd W et al. Bariatric surgery: shedding the monetary weight of prescription costs in the managed care arena. Obes Surg 2004; 14: 725-730.
25. Nguyen NT, Varela JE, Sabio A, Naim J, Stamos M, Wilson SE. Reduction in prescription medication costs after laparoscopic gastric bypass. Am Surg 2006; 72: 853-856.
26. Monk Jr JS, Dia Nagib N, Stehr W. Pharmaceutical savings after gastric bypass surgery. Obes Surg 2004; 14: 13-15.
27. Malone M, Alger-Mayer SA. Medication use patterns after gastric bypass surgery for weight management. Ann Pharmacother 2005; 39: 637-642.
28. Makary MA, Clarke JM, Shore AD, Magnuson TH, Richards T, Bass EB et al. Medication utilization and annual health care costs in patients with type 2 diabetes mellitus before and after bariatric surgery. Arch Surg 2010; 145: 726-731.
29. Gould JC, Garren MJ, Starling JR. Laparoscopic gastric bypass results in decreased prescription medication costs within 6 months. J Gastrointest Surg 2004; 8: 983-987.
30. Cremieux PY, Ledoux S, Clerici C, Cremieux F, Buessing M. The impact of bariatric surgery on comorbidities and medication use among obese patients. Obes Surg 2010; 20: 861-870.
31. Narbro K, Agren G, Jonsson E, Naslund I, Sjostrom L, Peltonen M. Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS intervention study. Arch Intern Med 2002; 162: 2061-2069.
32. Buchwald H, Oien DM. Metabolic/bariatric surgery Worldwide 2008. Obes Surg 2009; 19: 1605-1611.
33. Australian Department of Health and Ageing. Items for the surgical treatment of obesity. 2011; Available from: http://www.health.gov.au/internet/ main/publishing. nsf/Content/7C0B7F27D7F739B5CA25782A00821F3F/$File/ DRAFT%20obesity%20r eport.pdf. Accessed 15 May, 2012.
34. Australian Department of Health and Ageing. Pharmaceutical Benefits Schedule online. Available at http://www.pbs.gov.au/pbs/home. Accessed 11 May, 2011.
35. World Health Organisation. Collaborating Centre for Drug Statistics Methodology. Available at www.whocc.no/. Accessed 5 June 2011.
36. Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research. 4th ed. (Blackwell: Malden, MA, 2002.
37. Australian Institute of Health and Welfare. Health expenditure Australia 2008-09. Available from: http://www.aihw.gov.au/workarea/downloadasset.aspx?id= 6442472701. Accessed 18 May 2012.
38. Dixon JB, Murphy DK, Segel JE, Finkelstein EA. Impact of laparoscopic adjustable gastric banding on type 2 diabetes. Obes Rev 2012; 13: 57-67.
39. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-1737.
40. Simard B, Turcotte H, Marceau P, Biron S, Hould FS, Lebel S et al. Asthma and sleep apnea in patients with morbid obesity: outcome after bariatric surgery. Obes Surg 2004; 14: 1381-1388.
41. Hooper MM, Stellato TA, Hallowell PT, Seitz BA, Moskowitz RW. Musculoskeletal findings in obese subjects before and after weight loss following bariatric surgery. Int J Obes 2007; 31: 114-120.
42. Dixon JB, Chapman L, O'Brien P. Marked improvement in asthma after Lap-Band surgery for morbid obesity. Obes Surg 1999; 9: 385-389.
43. Herpertz S, Kielmann R, Wolf AM, Langkafel M, Senf W, Hebebrand J. Does obesity surgery improve psychosocial functioning? A systematic review. Int J Obes Relat Metab Disord 2003; 27: 1300-1314.
44. Kolotkin RL, Crosby RD, Gress RE, Hunt SC, Adams TD. Two-year changes in health-related quality of life in gastric bypass patients compared with severely obese controls. Surg Obes Relat Dis 2009; 5: 250-256.
45. Nickel MK, Loew TH, Bachler E. Change in mental symptoms in extreme obesity patients after gastric banding, Part II: Six-year follow up. Int J Psychiatry Med 2007; 37: 69-79.
46. Sarwer DB, Fabricatore AN, Jones-Corneille LR, Allison KC, Faulconbridge LN, Wadden TA. Psychological issues following bariatric surgery. Primary Psychiatry 2008; 15: 50-55.
47. Schowalter M, Benecke A, Lager C, Heimbucher J, Bueter M, Thalheimer A et al. Changes in depression following gastric banding: a 5-7-year prospective study. Obes Surg 2008; 18: 314-320.
48. Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean AP et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 2004; 240: 416-423, discussion 23-4.
49. Cremieux PY, Ledoux S, Clerici C, Cremieux F, Buessing M. The impact of bariatric surgery on comorbidities and medication use among obese patients. Obes Surg. Jul 20: 861-870.
50. Neovius M, Narbro K, Keating C, Peltonen M, Sjoholm K, Agren G et al. Health care use during 20 years following bariatric surgery. JAMA 2012; 308: 1132-1141.
51. Sampalis JS, Liberman M, Auger S, Christou NV. The impact of weight reduction surgery on health-care costs in morbidly obese patients. Obes Surg 2004; 14: 939-947.
52. Segal JB, Clark JM, Shore AD, Dominici F, Magnuson T, Richards TM et al. Prompt reduction in use of medications for comorbid conditions after bariatric surgery. Obes Surg 2009; 19: 1646-1656.
53. Mechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Spitz AF et al. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Obesity 2009; 17: S1-70v.
54. Dixon JB, Reuben Y, Halket C, O'Brien PE. Shoulder pain is a common problem following laparoscopic adjustable gastric band surgery. Obes Surg 2005; 15: 1111-1117.
55. Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess 2009; 13: 1-190215-357, iii-iv.
56. Salem L, Devlin A, Sullivan SD, Flum DR. Cost-effectiveness analysis of laparo-scopic gastric bypass, adjustable gastric banding, and nonoperative weight loss interventions. Surg Obes Relat Dis 2008; 4: 26-32.
57. Abdullah A, Stoelwinder J, Shortreed S, Wolfe R, Stevenson C, Walls H et al. The duration of obesity and the risk of type 2 diabetes. Public Health Nutr 2011; 14: 119-126.
58. Abdullah A, Wolfe R, Stoelwinder JU, de Courten M, Stevenson C, Walls HL et al. The number of years lived with obesity and the risk of all-cause and cause-specific mortality. Int J Epidemiol 2011; 40: 985-996.
59. Finkelstein EA, Allaire BT, Burgess SM, Hale BC. Financial implications of coverage for laparoscopic adjustable gastric banding. Surg Obes Relat Dis 2011; 7: 295-303.
60. Australian Department of Health and Ageing. Clinical Practice Guidelines for the Management of Overweight and Obesity in Adults http://www.health.gov. au/internet/main/publishing.nsf/Content/obesityguidelinesguidelines-adults.htm. Accessed 2 January, 2011.
61. Fried M, Hainer V, Basdevant A, Buchwald H, Deitel M, Finer N et al. Inter-disciplinary European guidelines on surgery of severe obesity. Int J Obes 2007; 31: 569-577.
62. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr 1992; 55: 615S-619SS.
63. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122: 248-56 e5.
64. Alemayehu B, Warner KE. The lifetime distribution of health care costs. Health Serv Res 2004; 39: 627-642.
65. Kraja AT, Borecki IB, North K, Tang W, Myers RH, Hopkins PN et al. Longitudinal and age trends of metabolic syndrome and its risk factors: the Family Heart Study. Nutr Metab 2006; 3: 41.